1 |
HINDRICKS G, POTPARA T, DAGRES N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC[J]. Eur Heart J, 2021, 42(5): 373-498.
|
2 |
SHI S B, TANG Y H, ZHAO Q Y, et al. Prevalence and risk of atrial fibrillation in China: a national cross-sectional epidemiological study[J]. Lancet Reg Health West Pac, 2022, 23: 100439.
|
3 |
BALL J, CARRINGTON M J, STEWART S, et al. Mild cognitive impairment in high-risk patients with chronic atrial fibrillation: a forgotten component of clinical management?[J]. Heart, 2013, 99(8): 542-547.
|
4 |
LIVINGSTON G, SOMMERLAD A, ORGETA V, et al. Dementia prevention, intervention, and care[J]. Lancet, 2017, 390(10113): 2673-2734.
|
5 |
de BRUIJN R F A G, HEERINGA J, WOLTERS F J, et al. Association between atrial fibrillation and dementia in the general population[J]. JAMA Neurol, 2015, 72(11): 1288-1294.
|
6 |
JARED T, BUNCH, MD, et al. Atrial fibrillation is independently associated with senile, vascular, and Alzheimer's dementia[J]. Heart Rhythm, 2010, 7(4): 433-437.
|
7 |
SINGH-MANOUX A, FAYOSSE A, SABIA S, et al. Atrial fibrillation as a risk factor for cognitive decline and dementia[J]. Eur Heart J, 2017, 38(34): 2612-2618.
|
8 |
KALANTARIAN S, STERN T A, MANSOUR M, et al. Cognitive impairment associated with atrial fibrillation: a meta-analysis[J]. Ann Intern Med, 2013, 158(5 Pt 1): 338-346.
|
9 |
EMDIN C A, KHERA A V, KATHIRESAN S. Mendelian randomization[J]. JAMA, 2017, 318(19): 1925.
|
10 |
王玉琢, 沈洪兵. 孟德尔随机化研究应用于因果推断的影响因素及其结果解读面临的挑战[J]. 中华流行病学杂志, 2020, 41(8): 1231-1236.
|
|
WANG Y Z, SHEN H B. Challenges and factors that influencing causal inference and interpretation, based on Mendelian randomization studies[J]. Chinese Journal of Epidemiology, 2020, 41(8): 1231-1236.
|
11 |
BOEF A G C, DEKKERS O M, LE CESSIE S. Mendelian randomization studies: a review of the approaches used and the quality of reporting[J]. Int J Epidemiol, 2015, 44(2): 496-511.
|
12 |
NIELSEN J B, THOROLFSDOTTIR R B, FRITSCHE L G, et al. Biobank-driven genomic discovery yields new insight into atrial fibrillation biology[J]. Nat Genet, 2018, 50(9): 1234-1239.
|
13 |
LEE J J, WEDOW R, OKBAY A, et al. Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals[J]. Nat Genet, 2018, 50(8): 1112-1121.
|
14 |
SCHWARTZENTRUBER J, COOPER S, LIU J Z, et al. Genome-wide meta-analysis, fine-mapping and integrative prioritization implicate new Alzheimer′s disease risk genes[J]. Nat Genet, 2021, 53(3): 392-402.
|
15 |
CHIA R, SABIR M S, BANDRES-CIGA S, et al. Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture[J]. Nat Genet, 2021, 53(3): 294-303.
|
16 |
van DEERLIN V M, SLEIMAN P M A, MARTINEZ-LAGE M, et al. Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions[J]. Nat Genet, 2010, 42(3): 234-239.
|
17 |
BURGESS S, BUTTERWORTH A, THOMPSON S G. Mendelian randomization analysis with multiple genetic variants using summarized data[J]. Genet Epidemiol, 2013, 37(7): 658-665.
|
18 |
BOWDEN J, DAVEY SMITH G, BURGESS S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression[J]. Int J Epidemiol, 2015, 44(2): 512-525.
|
19 |
BURGESS S, DAVEY SMITH G, DAVIES N M, et al. Guidelines for performing Mendelian randomization investigations: update for summer 2023[J]. Wellcome Open Res, 2023, 4: 186.
|
20 |
ALESSANDRA, MARENGONI,. Atrial fibrillation, stroke and dementia in the very old: a population-based study[J]. Neurobiol Aging, 2011, 32(7): 1336-1337.
|
21 |
HARING B, LENG X Y, ROBINSON J, et al. Cardiovascular disease and cognitive decline in postmenopausal women: results from the Women′s Health Initiative Memory Study[J]. J Am Heart Assoc, 2013, 2(6): e000369.
|
22 |
PETERS R, POULTER R, BECKETT N, et al. Cardiovascular and biochemical risk factors for incident dementia in the Hypertension in the Very Elderly Trial[J]. J Hypertens, 2009, 27(10): 2055-2062.
|
23 |
ODUTAYO A, WONG C X, HSIAO A J, et al. Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis[J]. BMJ, 2016, 354: i4482.
|
24 |
NISHTALA A, PIERS R J, HIMALI J J, et al. Atrial fibrillation and cognitive decline in the Framingham Heart Study[J]. Heart Rhythm, 2018, 15(2): 166-172.
|
25 |
DIENER H C, HART R G, KOUDSTAAL P J, et al. Atrial fibrillation and cognitive function: JACC review topic of the week[J]. J Am Coll Cardiol, 2019, 73(5): 612-619.
|
26 |
HU Y F, CHEN Y J, LIN Y J, et al. Inflammation and the pathogenesis of atrial fibrillation[J]. Nat Rev Cardiol, 2015, 12(4): 230-243.
|
27 |
ENCIU A M, POPESCU B O. Is there a causal link between inflammation and dementia?[J]. Biomed Res Int, 2013, 2013: 316495.
|
28 |
BANERJEE G, CHAN E, AMBLER G, et al. Cognitive impairment before atrial fibrillation-related ischemic events: neuroimaging and prognostic associations[J]. J Am Heart Assoc, 2020, 9(1): e014537.
|
29 |
de TORRE J C. Cardiovascular risk factors promote brain hypoperfusion leading to cognitive decline and dementia[J]. Cardiovasc Psychiatry Neurol, 2012, 2012: 367516.
|
30 |
LARSSON S C. Mendelian randomization as a tool for causal inference in human nutrition and metabolism[J]. Curr Opin Lipidol, 2021, 32(1): 1-8.
|
31 |
van OORT S, BEULENS J W J, van BALLEGOOIJEN A J, et al. Association of cardiovascular risk factors and lifestyle behaviors with hypertension: a Mendelian randomization study[J]. Hypertension, 2020, 76(6): 1971-1979.
|
32 |
PAN Y S, WANG Y L, WANG Y J. Investigation of causal effect of atrial fibrillation on alzheimer disease: a Mendelian randomization study[J]. J Am Heart Assoc, 2020, 9(2): e014889.
|